171 related articles for article (PubMed ID: 23140280)
1. Animal models of carcinogenesis in inflamed colorectum: potential use in chemoprevention study.
Tanaka T
Curr Drug Targets; 2012 Dec; 13(14):1689-97. PubMed ID: 23140280
[TBL] [Abstract][Full Text] [Related]
2. Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis.
Tanaka T
Cancers (Basel); 2012 Jul; 4(3):673-700. PubMed ID: 24213461
[TBL] [Abstract][Full Text] [Related]
3. Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention.
Tanaka T
Int J Inflam; 2012; 2012():658786. PubMed ID: 22518340
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
Yang GY; Taboada S; Liao J
Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Ehrlich AC; Patel S; Meillier A; Rothstein RD; Friedenberg FK
Expert Rev Anticancer Ther; 2017 Mar; 17(3):247-255. PubMed ID: 28095263
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model.
Girardi B; Principi M; Pricci M; Giorgio F; Iannone A; Losurdo G; Ierardi E; Di Leo A; Barone M
Carcinogenesis; 2018 Oct; 39(10):1274-1282. PubMed ID: 30084990
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer.
Talero E; Ávila-Roman J; Motilva V
Curr Pharm Des; 2012; 18(26):3939-65. PubMed ID: 22632755
[TBL] [Abstract][Full Text] [Related]
8. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colorectal cancer: feasibility in everyday practice?
Herszényi L; Farinati F; Miheller P; Tulassay Z
Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
[TBL] [Abstract][Full Text] [Related]
12. Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease.
Eaden J
Aliment Pharmacol Ther; 2003 Sep; 18 Suppl 2():15-21. PubMed ID: 12950416
[TBL] [Abstract][Full Text] [Related]
13. [Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases].
Ioffe AIu
Lik Sprava; 2005 Jun; (4):45-8. PubMed ID: 16158715
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
15. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
Yarla NS; Madka V; Pathuri G; Rao CV
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
[TBL] [Abstract][Full Text] [Related]
16. Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.
Luan Z; Ma Y; Xin Y; Qian J; Wang H
Curr Med Chem; 2017; 24(9):911-917. PubMed ID: 27915990
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
18. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
[TBL] [Abstract][Full Text] [Related]
19. Colitis-associated neoplasia: molecular basis and clinical translation.
Foersch S; Neurath MF
Cell Mol Life Sci; 2014 Sep; 71(18):3523-35. PubMed ID: 24830703
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice.
Tian Y; Wang K; Wang Z; Li N; Ji G
Carcinogenesis; 2013 Jul; 34(7):1593-600. PubMed ID: 23471883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]